Scientists at Rockefeller University found that arginine, an amino acid obtained from food and made naturally by the body, helps the immune system recognize cancer and viral threats. When arginine levels drop, cells cannot produce enough MHC-1, a protein that displays warning signals on cell surfaces to alert immune cells to danger.
Sohail Tavazoie's team, led by postdoc Qiushuang Wu, published their findings in Cell. They discovered that ribosomes, the cellular machines that assemble proteins, stall when trying to build MHC-1 proteins without sufficient arginine. This causes fewer warning signals to reach cell surfaces, allowing cancer and infected cells to evade detection.
In mouse experiments, increasing dietary arginine reduced colon cancer tumors and lessened the severity of influenza and SARS-CoV-2 infections. Providing arginine after mice contracted influenza also improved their outcomes. The amount needed was comparable to a couple of over-the-counter supplement tablets.
"Our work reveals how a lack of arginine interferes with the immune system, and suggests that upping arginine intake could prove beneficial," Wu said. "Perhaps that means it could be used in combination with other therapies to treat both cancer and viral infections."
Tavazoie noted that arginine supplementation could be readily tested in patients receiving immunotherapies or in high-risk populations exposed to viral pathogens. However, the researchers stressed that further human studies are needed to determine whether the benefits seen in mice translate to effective treatments for people.